Skip to main content

Articles

Page 3 of 8

  1. Authors: Shinya Tsuboi, Tatsuya Hayama, Katsuhiro Miura, Akihiro Uchiike, Daisuke Tsutsumi, Takashi Yamauchi, Yoshihiro Hatta and Susumu Ootsuka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:16
    Content type: Correction Published on:

    The original article was published in Journal of Pharmaceutical Health Care and Sciences 2023 9:2

  2. Rhabdomyolysis is a potentially life-threatening disease caused by melting or necrosis of skeletal muscle cells and leakage of muscle components into the bloodstream. It has been reported that the interaction ...

    Authors: Keiki Sakurama, Yuki Iguchi, Sara Haruki, Yusuke Hata, Madoka Hiraga, Shinya Yumoto and Yutaka Kai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:13
    Content type: Case report Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2023 9:17

  3. Drug-drug interaction management is complex. Nirmatrelvir/ritonavir is a potent cytochrome P450 (CYP) 3A inhibitor and influences pharmacokinetics of co-administered drugs. Although there are several reports a...

    Authors: Ayumi Tsuzawa, Yoshiki Katada, Keisuke Umemura, Mitsuhiro Sugimoto, Asami Nishikawa, Yu-ki Sato, Yuko Yoshida, Noriaki Kitada, Atsushi Yonezawa, Daisuke Nakajima, Hiroshi Date and Tomohiro Terada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:12
    Content type: Case report Published on:

  4. Fluconazole (FLCZ) inhibits cytochrome P450 (CYP) 2C9, 2C19, and 3A4 and has a drug-drug interaction that potentiates the effects of warfarin and prolong the prothrombin time-international normalized ratio (PT...

    Authors: Hayato Akamatsu, Hiroo Nakagawa, Ichiro Matsumaru, Junya Hashizume, Hitomi Harasawa, Yukinobu Kodama, Takashi Miura and Kaname Ohyama
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:11
    Content type: Case report Published on:

  5. Polypharmacy, defined as the concurrent use of over six drugs, is common in the treatment of heart failure (HF); however, unpredictable drug interactions with bepridil may occur. In this study, we have elucida...

    Authors: Yuki Asai, Hiroki Arihara, Saki Omote, Ena Tanio, Saena Yamashita, Takashi Higuchi, Ei Hashimoto, Momoko Yamada, Hinako Tsuji, Yoshihiro Kondo, Makoto Hayashi and Yoshiaki Yamamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:10
    Content type: Research article Published on:

  6. Supporting people living with HIV using anti-retroviral therapy (ART) is important due to the requirement for strict medication adherence. To date, no data from longitudinal studies evaluating adherence by tre...

    Authors: Yusuke Sekine, Takashi Kawaguchi, Yusuke Kunimoto, Junichi Masuda, Ayako Numata, Atsushi Hirano, Hiroki Yagura, Masashi Ishihara, Shinichi Hikasa, Mariko Tsukiji, Tempei Miyaji, Takuhiro Yamaguchi, Ei Kinai and Kagehiro Amano
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:9
    Content type: Research article Published on:

  7. There is no unified view of the necessity of prophylactic antimicrobial agents in trabeculectomy. Preoperative prophylactic antimicrobial agent injection and cefazolin sodium (CEZ) for trabeculectomy were disc...

    Authors: Yuuka Ushio, Hiroshi Yoshikawa, Tetsuya Murase, Tatsuo Kataoka, Shohei Miyamoto, Kazunari Maruko, Shoko Okamoto, Yuuka Shibata, Ryotaro Toda, Yoshiaki Kiuchi and Hiroaki Matsuo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:8
    Content type: Short report Published on:

  8. Cancer-related fatigue (CRF) is one of the most common symptoms in patients with cancer. However, CRF has not been sufficiently evaluated as it involves various factors. In this study, we evaluated fatigue in ...

    Authors: Takuya Fujihara, Motohiko Sano, Yutaka Negoro, Shinji Yamashita, Hideya Kokubun and Ryoichi Yano
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:7
    Content type: Research article Published on:

  9. One-dose packaging is frequently used in Japan for elderly patients who are prescribed several medications. It is useful for easy administration and the prevention of misuse or missed medications. Hygroscopic ...

    Authors: Taisuke Matsuo, Takayuki Yoshida, Kiyotaka Ushijima, Takashi Doi, Yasuyuki Sadzuka and Takashi Tomita
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:6
    Content type: Research article Published on:

  10. We aimed to evaluate the factors associated with baloxavir prescription in Japanese hospitals using a health insurance claim-based database (MDV analyzer), during the 2018/2019 and 2019/2020 influenza seasons....

    Authors: Naomi Fujiwara, Takashi Fujiwara and Yuya Ise
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:3
    Content type: Short report Published on:

  11. For pharmacists expected to encounter the deaths of many of their patients in the near future, it is important to understand the perception of a “good death” for patients with cancer who are likely to be aware...

    Authors: Reiko Konishi, Junichi Isogai, Akira Mukai, Koji Komori, Takashi Majima, Shinji Ito and Kou Kawada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:5
    Content type: Research article Published on:

  12. Dasatinib, which is used to treat treating chronic myeloid leukemia, induces increases in blood lymphocytes during the treatment. In addition, neutrophil–lymphocyte count ratio (NLR) is associated with the rel...

    Authors: Hirokazu Nakayama, Hiromitsu Iizuka, Toshiaki Kato and Kensuke Usuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:4
    Content type: Short report Published on:

  13. Pegfilgrastim is widely used for the prevention of febrile neutropenia (FN) in patients receiving myelosuppressive chemotherapy for various types of cancer. However, pegfilgrastim-induced bone pain (PIBP) is a...

    Authors: Shinya Tsuboi, Tatsuya Hayama, Katsuhiro Miura, Akihiro Uchiike, Daisuke Tsutsumi, Takashi Yamauchi, Yoshihiro Hatta and Susumu Ootsuka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:2
    Content type: Short report Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2023 9:16

  14. Mycophenolate mofetil (MMF), a prodrug of the immunosuppressive agent mycophenolic acid (MPA), is difficult to administer because of the pharmacokinetic complexity of MPA. Although dosage adjustment according ...

    Authors: Tomoko Mizaki, Hironobu Nobata, Shogo Banno, Makoto Yamaguchi, Hiroshi Kinashi, Shiho Iwagaitsu, Takuji Ishimoto, Yukiko Kuru, Masafumi Ohnishi, Ken-ichi Sako and Yasuhiko Ito
    Citation: Journal of Pharmaceutical Health Care and Sciences 2023 9:1
    Content type: Research Article Published on:

  15. Long-term use of proton pump inhibitors (PPIs) has been found to significantly lower serum magnesium levels in patients in the USA and Europe. The package inserts of PPIs in these countries clearly state that ...

    Authors: Nobuhiko Nakamura, Kanaha Yoneda, Takashi Higo and Masaaki Kusumoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:35
    Content type: Research article Published on:

  16. The number of medications, number of administrations per day, dosing frequency on indicated day, and medication from multiple prescriptions are the medication factors prone to medication errors in self-managem...

    Authors: Ryohei Suzuki, Takako Uchiya, Takamasa Sakai, Masaaki Takahashi and Fumiko Ohtsu
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:37
    Content type: Research article Published on:

  17. Human soluble recombinant thrombomodulin (TM alfa), a treatment for septic Disseminated intravascular coagulation (DIC), is recommended for patients with severe renal dysfunction in reduced doses. However, no ...

    Authors: Yoshihiro Nishita, Masatoshi Taga, Masaru Sakurai, Yoshitsugu Iinuma and Togen Masauji
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:32
    Content type: Research article Published on:

  18. Inappropriate medication prescribing and dispensing by physicians and pharmacists is a preventable cause of morbidity and mortality in the elderly. Signifying the importance of healthcare professionals’ knowle...

    Authors: Wuraola Akande-Sholabi and Adeola Fafemi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:36
    Content type: Research article Published on:

  19. Allopurinol is used to treat hyperuricemia and gout. It is metabolized to oxypurinol by xanthine oxidase (XO), and aldehyde oxidase (AO). Allopurinol and oxypurinol are potent XO inhibitors that reduce the pla...

    Authors: Yoshitaka Tayama, Kazumi Sugihara, Seigo Sanoh, Katsushi Miyake, Shigeyuki Kitamura and Shigeru Ohta
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:31
    Content type: Research article Published on:

  20. During the coronavirus disease (COVID-19) pandemic, general strategies for preventing infectious diseases, such as social distancing and the use of protective equipment have resulted in communication barriers ...

    Authors: Masaki Maehara and Masayasu Sugiyama
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:34
    Content type: Research article Published on:

  21. Immunotherapy with immune checkpoint inhibitors is associated with immune-related adverse events (irAEs). A positive correlation between treatment efficacy and irAEs has been reported. Clinical indicators are ...

    Authors: Maiko Machida, Chika Yamazaki, Nao Kouda, Yousei Hanai, Hideki Sato, Ainari Konda, Yuka Yamagata, Tatsuya Itho and Haruhiko Aisaka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:29
    Content type: Case report Published on:

  22. Gefitinib and erlotinib, are epidermal growth factor receptor tyrosine kinase inhibitors, and are currently recommended for non-small cell lung cancer stage IV in the elderly and in patients with decreased per...

    Authors: Hirofumi Nagai, Tsutomu Shimada, Yoshimitsu Takahashi, Mikako Nishikawa, Hiroyuki Tozuka, Yasuto Yamamoto, Osamu Niwa, Yutaka Takahara, Arimi Fujita, Katsuhiko Nagase, Kazuo Kasahara, Seiji Yano and Yoshimichi Sai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:28
    Content type: Research article Published on:

  23. The impact of cumulative dose of cisplatin on gonadal function has not been clarified. We evaluated whether the cumulative cisplatin dose affects the resumption of menses in patients treated with bleomycin, et...

    Authors: Miki Akasaka, Toshinori Hirai, Kenta Yoshida, Eiji Kondo, Tomoaki Ikeda and Takuya Iwamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:33
    Content type: Short report Published on:

  24. Information sharing among medical professionals is important for providing quality medical care. The purpose of the present study was to elucidate the actual status of information sharing between hospitals and...

    Authors: Daisuke Kikuchi, Masami Tsuchiya, Shiro Hatakeyama, Yuichi Tasaka, Takeshi Uchikura, Ryohkan Funakoshi and Taku Obara
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:30
    Content type: Research article Published on:

  25. COVID-19 has become a significant health threat and a primary healthcare concern among the most vulnerable patients with cancer. Patients with COVID-19 who have lung cancer are at great risk and need careful m...

    Authors: Masatoshi Maki, Ryo Takada, Akihiko Taniguchi, Naoyuki Nomura, Seiichiro Kuramoto, Yuki Chiko, Toshiaki Okada, Seiji Saito and Koji Tamura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:27
    Content type: Research article Published on:

  26. It is possible that increased synthesis of metallothioneins (MTs), Zn2+-binding proteins is linked with the protective effect of Ninjin-yoei-to (NYT) on Zn2+ toxicity ferried by amyloid β1-42 (Aβ1-42).

    Authors: Haruna Tamano, Haruna Tokoro, Daichi Murakami, Rin Tsujimoto, Yuka Nishijima, Erina Tsuda, Satoshi Watanabe, Miki Suzuki and Atsushi Takeda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:26
    Content type: Research article Published on:

  27. Tacrolimus is a key drug in immunosuppressive therapy following lung transplantation. The blood tacrolimus levels are likely to fluctuate in the early postoperative period, and failure to maintain the tacrolim...

    Authors: Yoshiki Katada, Shunsaku Nakagawa, Kotaro Itohara, Takuya Suzuki, Ryota Kato, Hiroki Endo, Mitsuhiro Sugimoto, Atsushi Yonezawa, Takayuki Nakagawa, Akihiro Ohsumi, Daisuke Nakajima, Hiroshi Date and Tomohiro Terada
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:25
    Content type: Research article Published on:

  28. Although automated dispensing robots have been implemented for medication dispensing in Japan, their effect is yet to be fully investigated. In this study, we evaluated the effect of automated dispensing robot...

    Authors: Tomoki Takase, Norio Masumoto, Naoki Shibatani, Yusaku Matsuoka, Fumiaki Tanaka, Masaki Hirabatake, Hiroko Kashiwagi, Itaru Nishioka, Hiroaki Ikesue, Tohru Hashida, Naoshi Koide and Nobuyuki Muroi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:24
    Content type: Research article Published on:

  29. Pharmacists must understand the mechanisms by which dispensing errors occur and take appropriate preventive measures. In this study, the gaze movements of pharmacists were analyzed using an eye-tracking method...

    Authors: Toshikazu Tsuji, Kenichiro Nagata, Keiichi Sasaki, Ryosuke Matsukane, Shigeru Ishida, Takehiro Kawashiri, Kimitaka Suetsugu, Hiroyuki Watanabe, Takeshi Hirota and Ichiro Ieiri
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:23
    Content type: Research article Published on:

  30. We previously reported that high body weight was a risk factor affecting the onset of anti-epidermal growth factor receptor (EGFR) antibody drug-induced acneiform rash. The current study investigated the relat...

    Authors: Hiroaki Takahashi, Yukiko Yaegashi, Yoko Saito, Satoru Nihei, Tomohiko Tairabune, Haruki Ujiie, Junichi Asaka and Kenzo Kudo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:22
    Content type: Research article Published on:

  31. Cisplatin (CDDP)-induced nephrotoxicity is the most important complication of CDDP treatment. 5-Hydroxytryptamine type 3 receptor antagonists (5-HT3RAs) are widely used to prevent chemotherapy-induced nausea and ...

    Authors: Miho Takemura, Kenji Ikemura, Masayoshi Kondo, Fumihiro Yamane, Mikiko Ueda and Masahiro Okuda
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:21
    Content type: Research article Published on:

  32. Sulfamethoxazole/trimethoprim (SMX/TMP) potentially increases the serum creatinine levels, resulting in acute kidney injury (AKI). However, the clinical characteristics of the AKI associated with SMX/TMP and t...

    Authors: Yuki Shimizu, Toshinori Hirai, Yukari Ogawa, Chihiro Yamada and Emiko Kobayashi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:20
    Content type: Research article Published on:

  33. Patients with ulcerative colitis (UC) may be concerned about medication safety during preconception, pregnancy, and lactation, and they should be closely followed up to ensure that UC activity is controlled du...

    Authors: Jumpei Saito, Kayoko Kaneko, Hiroyo Kawasaki, Takeshi Hayakawa, Naho Yakuwa, Tomo Suzuki, Haruhiko Sago, Akimasa Yamatani and Atsuko Murashima
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:18
    Content type: Case report Published on:

  34. Linezolid is a new oxazolidinone antibiotic used for infections caused by methicillin-resistant Staphylococcus and other species.

    Authors: Daisuke Negishi, Okimichi Mitsumatsu, Takahiro Matsumura, Hiromi Mitsumatsu, Miaki Makiguchi, Makiko Shimizu and Hiroshi Yamazaki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:16
    Content type: Case report Published on:

  35. In Japan, engineering controls for preparing injectable anticancer drugs are inadequate and compliance with appropriate preparation procedures is vital. In this study, we evaluated the effects of adherence to ...

    Authors: Yuki Yanagisawa, Kazuo Isama, Tomohiro Kurosu, Yoshiaki Natsume, Toshikazu Seino, Tetsuji Nishimura and Atsushi Yamashita
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:19
    Content type: Research article Published on:

  36. Nelarabine is an antineoplastic purine analog used for the treatment of refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL). The most prominent side effect of nelarabine are neurotoxicity and he...

    Authors: Akari Utsumi, Yuri Goto, Takaaki Suzuki, Chiaki Imai, Shinichiro Matsui, Emiko Sakaida and Itsuko Ishii
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:17
    Content type: Case report Published on:

  37. Olanzapine has been shown to have an additive effect on the three-drug antiemetic therapy consisting of aprepitant, palonosetron, and dexamethasone, in a highly emetogenic cisplatin-containing chemotherapy. Al...

    Authors: Yu Kondo, Tomoya Tachi, Takayoshi Sakakibara, Jun Kato, Takahito Mizuno, Yoshio Miyake and Hitomi Teramachi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:15
    Content type: Research article Published on:

  38. In the European Union (EU), a Risk Management Plan (RMP) is submitted as part of the dossier for initial marketing authorization of a medicinal product or with an application involving a significant change to ...

    Authors: Suzan Esslinger, Linda Quinn, Sami Sampat, Marijo Otero-Lobato, Wim Noël, Anja Geldhof, Nicole Herijgers and Sarah-Jane Reeder
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:14
    Content type: Research article Published on:

  39. Acetaminophen-induced hypotension has been reported in critically ill patients; however, it remains unclear whether mannitol, present as a stabilizing compound in acetaminophen formulations, affects hemodynami...

    Authors: Shunsuke Inage, Ryo Yajima, Shintaro Nagahara, Aya Kazama, Moe Takamura, Tomohiro Shoji, Mika Kadoi, Yukiko Tashiro and Yuya Ise
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:13
    Content type: Research article Published on:

  40. Potentially inappropriate medications (PIMs) and polypharmacy in older adults lead to increase the risk of adverse drug events. This study aimed to evaluate the effectiveness of pharmacist intervention combini...

    Authors: Takeshi Kimura, Misa Fujita, Michiko Shimizu, Kasumi Sumiyoshi, Saho Bansho, Kazuhiro Yamamoto, Tomohiro Omura and Ikuko Yano
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:12
    Content type: Research article Published on:

  41. Postoperative nausea and vomiting (PONV) delays postoperative recovery, prolongs hospital stays, and hinders patients’ return to society, thus making it a major cause of increased healthcare costs. It is also ...

    Authors: Satoshi Nagase, Masaharu Imaura, Mizuki Nishimura, Kohei Takeda, Mari Takahashi, Hideki Taniguchi, Tomoyuki Sato and Hiroshi Kanno
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:11
    Content type: Research article Published on:

  42. A high prevalence of mental disorders including depression, anxiety, somatoform, and dissociative disorder is reported during pregnancy, however, information on the transfer of antipsychotics across the placen...

    Authors: Jumpei Saito, Yoshiyuki Tachibana, Yuka Sano Wada, Naho Yakuwa, Hiroyo Kawasaki, Tomo Suzuki, Haruhiko Sago, Akimasa Yamatani and Atsuko Murashima
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:10
    Content type: Case report Published on:

  43. We report a case of delayed excretion of methotrexate (MTX) in a pediatric patient on high-dose MTX therapy in response to a change in the concomitant dosage of voriconazole from oral to intravenous. As the in...

    Authors: Daisuke Watahiki, Daisuke Saito, Naonori Nishida, Hiroyuki Tsuri, Keiko Nomura, Yuichi Adachi and Masato Taguchi
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:9
    Content type: Case report Published on:

  44. The effect of pharmaceutical intervention to treat adverse events on quality of life (QOL) in outpatients receiving cancer chemotherapy is unclear. We investigated whether pharmaceutical intervention provided ...

    Authors: Hironori Fujii, Yukino Ueda, Chiemi Hirose, Koichi Ohata, Kumiko Sekiya, Mika Kitahora, Shiori Sadaka, Senri Yamamoto, Daichi Watanabe, Hiroko Kato-Hayashi, Hirotoshi Iihara, Ryo Kobayashi, Miho Kaburaki, Nobuhisa Matsuhashi, Takao Takahashi, Akitaka Makiyama…
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:8
    Content type: Research article Published on:

  45. Pharmacists guide patients in their use of traditional, complementary, and integrative medicine (TCIM). The present study aimed to evaluate the opinions of Japanese pharmacists regarding TCIM, and to evaluate ...

    Authors: Yoshiharu Motoo, Keiko Yukawa, Kazuho Hisamura and Ichiro Arai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:7
    Content type: Research article Published on:

  46. Voriconazole (VRCZ) is the first-line therapy for chronic pulmonary aspergillosis and is available in both intravenous and oral formulations. The bioavailability of the oral form is estimated to be over 90% in...

    Authors: Hiromi Kaneko, Shingo Yamazaki, Masashi Uchida, Takaaki Suzuki, Kentaro Murakami, Hisahiro Matsubara, Katsuhiko Kamei and Itsuko Ishii
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:6
    Content type: Case report Published on:

  47. Gemcitabine plus nab-paclitaxel (GnP) therapy is used for unresectable pancreatic ductal adenocarcinoma, but may cause interstitial lung disease (ILD) as a serious side effect. However, the risk factors for IL...

    Authors: Rikako Ueda, Naho Yamamoto, Yuki Hori, Kouji Yoshida, Koushiro Ohtsubo, Takeshi Terashima, Tsutomu Shimada and Yoshimichi Sai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:5
    Content type: Research article Published on:

  48. The blood concentration of cyclosporine (CyA) is frequently elevated following the transfusion of red blood cell concentrate (RCC) to patients after allogeneic hematopoietic stem cell transplantation (HSCT). T...

    Authors: Masashi Uchida, Natsumi Hanada, Shingo Yamazaki, Hirokazu Takatsuka, Chiaki Imai, Akari Utsumi, Yuki Shiko, Yohei Kawasaki, Takaaki Suzuki and Itsuko Ishii
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:4
    Content type: Research article Published on:

  49. The standard dose of vancomycin (VCM, 2 g/day) sometimes fails to achieve therapeutic concentration in patients with normal renal function. In this study, we aimed to identify factors to predict patients who r...

    Authors: Ryo Yamaguchi, Hiroko Kani, Takehito Yamamoto, Takehiro Tanaka and Hiroshi Suzuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:3
    Content type: Research article Published on:

  50. Casirivimab-imdevimab has been developed to neutralize SARS-CoV-2. The global clinical trials in outpatients documented several adverse effects (AE), which mandate caution in Japan where part of patients retur...

    Authors: Junichi Yoshida, Kenichiro Shiraishi, Tetsuro Tamura, Kazuhiro Otani, Tetsuya Kikuchi, Akiko Mataga, Takako Ueno and Masao Tanaka
    Citation: Journal of Pharmaceutical Health Care and Sciences 2022 8:1
    Content type: Short report Published on:
JSPHCS

Official journal of JSPHCS

Submit manuscript

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.2
    5-year Journal Impact Factor: 1.4
    Source Normalized Impact per Paper (SNIP): 0.557
    SCImago Journal Rank (SJR): 0.312

    Speed 2023
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 88

    Usage 2023
    Downloads: 407,928
    Altmetric mentions: 83

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us